Header Logo

Connection

KIM-ANH DO to Carcinoma, Neuroendocrine

Back to Details
This is a "connection" page, showing publications KIM-ANH DO has written about Carcinoma, Neuroendocrine.
KIM-ANH DO
Connection Strength
0.064
Carcinoma, Neuroendocrine
  1. PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors. Clin Cancer Res. 2012 Mar 15; 18(6):1777-89.
    View in: PubMed
    Score: 0.064
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.